Portal vein ligation alters coding and noncoding gene expression in rat livers

Area of Science:

• Hepatology
• Molecular Biology
• Surgical Oncology

Background:

• Portal vein occlusion (PVO) is used to increase resectability of unresectable liver cancer by promoting hypertrophy in non-occluded liver lobes.
• The precise molecular mechanisms driving PVO-induced hepatic hypertrophy remain largely unknown.
• Understanding these mechanisms is crucial for optimizing PVO as a therapeutic strategy.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying hepatic hypertrophy and regeneration following portal vein ligation (PVL).
• To identify differential gene expression profiles in ligated and non-ligated liver lobes after PVL.
• To explore the role of specific gene and RNA expression patterns in PVL-induced liver adaptation.

Main Methods:

• Utilized cDNA microarray to analyze gene expression in ligated liver lobes (LLLs) and non-ligated liver lobes (NLLLs) at various time points post-PVL.
• Performed bioinformatics and cluster analysis to identify significant gene expression patterns and temporal changes.
• Conducted Gene Ontology (GO) analysis to determine activated biological pathways.

Main Results:

• Significant differences in gene expression profiles were observed between LLLs and NLLLs post-PVL.
• Specific expression patterns (No. 22 and No. 5) showed altered gene expression from 24 hours to 14 days post-PVL.
• GO analysis indicated activation of hypoxia pathways in LLLs and cell proliferation/cell-cycle pathways in NLLLs.

Conclusions:

• PVL induces distinct molecular responses in different liver lobes, involving differential expression of coding and noncoding RNAs.
• Hypoxia in ligated lobes and cell proliferation in non-ligated lobes are key pathways involved in PVL-induced hypertrophy and regeneration.
• These findings provide critical insights into PVL mechanisms and identify potential therapeutic targets for liver cancer treatment.